125 related articles for article (PubMed ID: 35596585)
1. Outcomes of carotid sparing intensity-modulated radiotherapy for early stage glottic cancer in 201 patients: Multicenter study of Turkish Radiation Oncology Society/TROD-01-007.
Bicakci BC; Mustafayev TZ; Cetinayak O; Igdem S; Birgi SD; Meydan D; Demircioglu F; Atalar B; Ozyar E; Akman F
Head Neck; 2022 Aug; 44(8):1825-1832. PubMed ID: 35596585
[TBL] [Abstract][Full Text] [Related]
2. Comparative dosimetry of volumetric modulated arc therapy and limited-angle static intensity-modulated radiation therapy for early-stage larynx cancer.
Riegel AC; Antone J; Schwartz DL
Med Dosim; 2013; 38(1):66-9. PubMed ID: 22901745
[TBL] [Abstract][Full Text] [Related]
3. Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma.
Zumsteg ZS; Riaz N; Jaffery S; Hu M; Gelblum D; Zhou Y; Mychalczak B; Zelefsky MJ; Wolden S; Rao S; Lee NY
Oral Oncol; 2015 Jul; 51(7):716-23. PubMed ID: 25958831
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison of helical tomotherapy, intensity-modulated radiation therapy, volumetric-modulated arc therapy, and 3-dimensional conformal therapy for the treatment of T1N0 glottic cancer.
Ekici K; Pepele EK; Yaprak B; Temelli O; Eraslan AF; Kucuk N; Altınok AY; Sut PA; Alpak OD; Colak C; Mayadagli A
Med Dosim; 2016 Winter; 41(4):329-333. PubMed ID: 27765542
[TBL] [Abstract][Full Text] [Related]
5. Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer.
Rosenthal DI; Fuller CD; Barker JL; Mason B; Garcia JA; Lewin JS; Holsinger FC; Stasney CR; Frank SJ; Schwartz DL; Morrison WH; Garden AS; Ang KK
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):455-61. PubMed ID: 19679406
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation.
Mohamed ASR; Smith BD; Smith JB; Sevak P; Malek JS; Kanwar A; Browne T; Gunn GB; Garden AS; Frank SJ; Morrison WH; Phan J; Zafereo M; Skinner H; Lai SY; Hutcheson KA; Lewin JS; Hessel AE; Thekdi AA; Weber RS; Fuller CD; Rosenthal DI
Laryngoscope; 2020 Jan; 130(1):146-153. PubMed ID: 30756394
[TBL] [Abstract][Full Text] [Related]
7. Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.
Janssen S; Glanzmann C; Huber G; Studer G
Radiat Oncol; 2014 Jun; 9():136. PubMed ID: 24923417
[TBL] [Abstract][Full Text] [Related]
8. Improving target dose coverage and organ-at-risk sparing in intensity-modulated radiotherapy of advanced laryngeal cancer by a simple optimization technique.
Lu JY; Wu LL; Zhang JY; Zheng J; Cheung ML; Ma CC; Xie LX; Huang BT
Br J Radiol; 2015 Feb; 88(1046):20140654. PubMed ID: 25494885
[TBL] [Abstract][Full Text] [Related]
9. Standardisation of Target Volume Delineation for Carotid-sparing Intensity-modulated Radiotherapy in Early Glottis Cancer.
Gujral DM; Long M; Roe JW; Harrington KJ; Nutting CM
Clin Oncol (R Coll Radiol); 2017 Jan; 29(1):42-50. PubMed ID: 27815039
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated radiotherapy for early glottic cancer: transition to a new standard of care?
Samuels MA; Freedman LM; Elsayyad N
Future Oncol; 2016 Nov; 12(22):2615-2630. PubMed ID: 27502431
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric comparison of intensity-modulated radiation therapy for early-stage glottic cancers with and without the air cavity in the planning target volume.
Asher D; Amestoy W; Studenski MT; Samuels SE; Abramowitz MC; Freedman LM; Elsayyad N; Samuels MA
Med Dosim; 2019 Winter; 44(4):405-408. PubMed ID: 30928177
[TBL] [Abstract][Full Text] [Related]
12. Clinical and dosimetric implications of intensity-modulated radiotherapy for early-stage glottic carcinoma.
Ward MC; Pham YD; Kotecha R; Zakem SJ; Murray E; Greskovich JF
Med Dosim; 2016; 41(1):64-9. PubMed ID: 26553472
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.
Lambrecht M; Nevens D; Nuyts S
Strahlenther Onkol; 2013 Mar; 189(3):223-9. PubMed ID: 23319256
[TBL] [Abstract][Full Text] [Related]
14. Effects of full-neck volumetric-modulated arc therapy vs split-field intensity-modulated head and neck radiation therapy on low neck targets and structures.
Anamalayil SJ; Teo BK; Lin A; Lustig RA; Ahn PH
Br J Radiol; 2016 Jun; 89(1062):20160009. PubMed ID: 27043353
[TBL] [Abstract][Full Text] [Related]
15. Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer.
Ding C; Chun SG; Sumer BD; Nedzi LA; Abdulrahman RE; Yordy JS; Lee P; Hrycushko B; Solberg TD; Ahn C; Timmerman RD; Schwartz DL
Med Dosim; 2017 Summer; 42(2):90-96. PubMed ID: 28438431
[TBL] [Abstract][Full Text] [Related]
16. Volumetric arc intensity-modulated therapy for spine body radiotherapy: comparison with static intensity-modulated treatment.
Wu QJ; Yoo S; Kirkpatrick JP; Thongphiew D; Yin FF
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1596-604. PubMed ID: 19733447
[TBL] [Abstract][Full Text] [Related]
17. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage.
Karpf D; Sakka M; Metzger M; Grabenbauer GG
Radiat Oncol; 2019 Sep; 14(1):156. PubMed ID: 31477165
[TBL] [Abstract][Full Text] [Related]
18. Intensity-Modulated Radiation Therapy for Early-Stage Squamous Cell Carcinoma of the Glottic Larynx: A Systematic Review and Meta-Analysis.
Razavian NB; D'Agostino RB; Shenker RF; Hughes RT
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):652-663. PubMed ID: 37150263
[TBL] [Abstract][Full Text] [Related]
19. SmartArc-based volumetric modulated arc therapy can improve the middle ear, vestibule and cochlea sparing for locoregionally advanced nasopharyngeal carcinoma: a dosimetric comparison with step-and-shoot intensity-modulated radiotherapy.
Gao J; Qian TL; Tao CZ; Zhang YH; Zhou Y; Yang J; He J; Wang R; Zhou PJ
Br J Radiol; 2015 Sep; 88(1053):20150052. PubMed ID: 26111068
[TBL] [Abstract][Full Text] [Related]
20. Carotid-Sparing TomoHelical 3-Dimensional Conformal Radiotherapy for Early Glottic Cancer.
Hong CS; Oh D; Ju SG; Ahn YC; Noh JM; Chung K; Kim JS; Suh TS
Cancer Res Treat; 2016 Jan; 48(1):63-70. PubMed ID: 25761477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
